A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome | MicrobiomeTrials← Back to trialsNCT07503444
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-05-31Est. Completion: 2028-08-01
Enrollment target: 200 participants Locations- Ep0247 21010, Little Rock, Arkansas, United States
- Ep0247 21005, Houston, Texas, United States
- Ep0247 15001, Budapest, Hungary
- Ep0247 43006, Musashimurayama-shi, Japan
Other microbiome trials you might be interested in
Rett Syndrome
Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leadi…
Fortaleza, BrazilCompleted Jun 2027
Rett Syndrome
This study will evaluate the efficacy and safety profiles of the investigational gene therapy, NGN-401, in females with …
Birmingham, United StatesEst. completion Dec 2029